Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTR

SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTR

Resource Type

CF Research News

Authors

Alice C Eastman, Rhonda G Pace, Hong Dang, Melis Atalar Aksit, Briana Vecchio-Pagán, Anh-Thu N Lam, Wanda K O'Neal, Scott M Blackman, Michael R Knowles, Garry R Cutting

References

J Cyst Fibros. 2021 Mar 2;S1569-1993(21)00042-4. doi: 10.1016/j.jcf.2021.02.007.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

G551D [3]
Ivacaftor efficacy [4]
Modifier genes [5]
SLC26A9 rs7512462 [6]

Date

Tuesday, March 2, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/slc26a9-snp-rs7512462-not-associated-lung-disease-severity-or-lung

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-20-00348R1_FINAL_Moore_070321_0.pdf [2] https://pubmed.ncbi.nlm.nih.gov/33674211/ [3] https://www.ecfs.eu/research-article-keywords/g551d [4] https://www.ecfs.eu/research-article-keywords/ivacaftor-efficacy [5] https://www.ecfs.eu/research-article-keywords/modifier-genes [6] https://www.ecfs.eu/research-article-keywords/slc26a9-rs7512462 [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines